Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03001882
Title An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Acronym CheckMate 592
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ITA | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Local Institution - 0006 Springdale Arkansas 72762 United States Details
Local Institution - 0001 New Haven Connecticut 06520 United States Details
Local Institution - 0005 Jacksonville Florida 32256 United States Details
Local Institution - 0009 Atlanta Georgia 30322 United States Details
Local Institution - 0003 Saint Louis Missouri 63110 United States Details
Local Institution - 0038 Bronx New York 10461 United States Details
Local Institution - 0002 Cleveland Ohio 44195 United States Details
Local Institution - 0008 Cleveland Ohio 44195 United States Details
Local Institution - 0007 Greenville South Carolina 29607 United States Details
Local Institution - 0004 Nashville Tennessee 37203 United States Details
Local Institution - 0017 La Louvière Hainaut 7100 Belgium Details
Local Institution - 0018 Gent 9000 Belgium Details
Local Institution - 0028 Gent 9000 Belgium Details
Local Institution - 0027 Liege 4000 Belgium Details
Local Institution - 0016 Sint-Niklaas 9100 Belgium Details
Local Institution - 0036 Paris Cedex 5 75248 France Details
Local Institution - 0033 Pierre Benite 69495 France Details
Local Institution - 0034 Strasbourg Cedex 67091 France Details
Local Institution - 0039 Toulon 83000 France Details
Local Institution - 0015 Essen 45136 Germany Details
Local Institution - 0014 Immenstadt 87509 Germany Details
Local Institution - 0013 Loewenstein 74245 Germany Details
Local Institution - 0012 Stuttgart 70174 Germany Details
Local Institution - 0023 Bergamo 24127 Italy Details
Local Institution - 0025 Catania 95123 Italy Details
Local Institution - 0026 Parma 43100 Italy Details
Local Institution - 0024 Perugia 06129 Italy Details
Local Institution - 0021 Amsterdam 1066 CX Netherlands Details
Local Institution - 0022 Nijmegen 6525 GA Netherlands Details
Local Institution - 0011 Cluj-Napoca Cluj 400015 Romania Details
Local Institution - 0010 Craiova 200542 Romania Details
Local Institution - 0031 Barcelona 08908 Spain Details
Local Institution - 0029 Madrid 28041 Spain Details
Local Institution - 0030 Madrid 28046 Spain Details
Local Institution - 0032 Sevilla 41009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field